Protein tyrosine phosphatases in multiple myeloma
Peer reviewed, Journal article
Published version

View/ Open
Date
2020Metadata
Show full item recordCollections
- Institutt for klinisk og molekylær medisin [3673]
- Publikasjoner fra CRIStin - NTNU [39811]
- St. Olavs hospital [2681]
Original version
10.1016/j.canlet.2020.11.042Abstract
Many cell signaling pathways are activated or deactivated by protein tyrosine phosphorylation and dephosphorylation, catalyzed by protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs), respectively. Even though PTPs are as important as PTKs in this process, their role has been neglected for a long time. Multiple myeloma (MM) is a cancer of plasma cells, which is characterized by production of monoclonal immunoglobulin, anemia and destruction of bone. MM is still incurable with high relapse frequency after treatment. In this review, we highlight the PTPs that were previously described in MM or have a role that can be relevant in a myeloma context. Our purpose is to show that despite the importance of PTPs in MM pathogenesis, many unanswered questions in this field need to be addressed. This might help to detect novel treatment strategies for MM patients.